| Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome GG Schwartz, PG Steg, M Szarek, DL Bhatt, VA Bittner, R Diaz, et al. New England Journal of Medicine 379, 2097-2107, 2018 | 2626 | 2018 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … SPG Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA ... Lancet Diabetes Endocrinol. 7 (8), 618-628, 2019 | 247 | 2019 |
| Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse M Lovric-Bencic, P Sikiric, JS Hanzevacki, S Seiwerth, D Rogic, V Kusec, ... Journal of pharmacological sciences 95 (1), 19-26, 2004 | 138 | 2004 |
| Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system D Balenovic, ML Bencic, M Udovicic, K Simonji, JS Hanzevacki, I Barisic, ... Regulatory peptides 156 (1-3), 83-89, 2009 | 117 | 2009 |
| Achilles Detachment in Rat and Stable Gastric Pentadecapeptide BPC 157: Promoted Tendon‐to‐Bone Healing and Opposed Corticosteroid Aggravation A Krivic, T Anic, S Seiwerth, D Huljev, P Sikiric Journal of orthopaedic research 24 (5), 982-989, 2006 | 100 | 2006 |
| Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157 I Barisic, D Balenovic, R Klicek, B Radic, B Nikitovic, D Drmic, M Udovicic, ... Regulatory peptides 181, 50-66, 2013 | 94 | 2013 |
| A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine P Sikiric, A Marovic, W Matoz, T Anic, G Buljat, D Mikus, ... Journal of Physiology-Paris 93 (6), 505-512, 1999 | 89 | 1999 |
| Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study) Ž Reiner, šime Mihatov, D Miličić, M Bergovec, D Planinc, ... European Journal of Preventive Cardiology 13 (4), 646-654, 2006 | 82 | 2006 |
| Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol … I Prkacin, J Separovic, G Aralicia, D Perovic, M Gjurasin, M Lovric-Bencic, ... Journal of Physiology-Paris 95 (1-6), 315-324, 2001 | 79 | 2001 |
| Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications P Sikiric, S Seiwerth, R Rucman, D Kolenc, L Batelja Vuletic, D Drmic, ... Current neuropharmacology 14 (8), 857-865, 2016 | 78 | 2016 |
| Lipoprotein (a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol GG Schwartz, M Szarek, VA Bittner, R Diaz, SG Goodman, JW Jukema, ... Journal of the American College of Cardiology 78 (5), 421-433, 2021 | 73 | 2021 |
| Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide … S Skorjanec, Z Dolovski, I Kocman, L Brcic, A Blagaic Boban, L Batelja, ... Digestive diseases and sciences 54, 46-56, 2009 | 73 | 2009 |
| Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide … S Skorjanec, Z Dolovski, I Kocman, L Brcic, A Blagaic Boban, L Batelja, ... Digestive diseases and sciences 54, 46-56, 2009 | 73 | 2009 |
| Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats. I Prkacin, G Aralica, D Perovic, J Separovic, M Gjurasin, M Lovric-Bencic, ... Journal of Physiology-Paris 95 (1-6), 295-301, 2001 | 65 | 2001 |
| Stress in gastrointestinal tract and stable gastric pentadecapeptide BPC 157. Finally, do we have a solution? P Sikiric, S Seiwerth, R Rucman, D Drmic, M Stupnisek, A Kokot, M Sever, ... Current pharmaceutical design 23 (27), 4012-4028, 2017 | 58 | 2017 |
| Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and … P Sikiric, S Seiwerth, Z Grabarevic, I Balen, G Aralica, M Gjurasin, ... Journal of Physiology-Paris 95 (1-6), 261-270, 2001 | 56 | 2001 |
| Five-year angiographic and clinical follow-up of patients with drug-eluting stent implantation for symptomatic myocardial bridging in absence of coronary atherosclerotic disease A Ernst, J Bulum, J Separovic Hanzevacki, M Lovric Bencic, M Strozzi J Invasive Cardiol 25 (11), 586-592, 2013 | 55 | 2013 |
| Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157 P Sikiric, J Šeparovic, G Buljat, T Anic, D Stancic-Rokotov, D Mikus, ... Journal of Physiology-Paris 94 (2), 105-110, 2000 | 55 | 2000 |
| Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and … I Bilic, I Zoricic, T Anic, J Separovic, D Stancic-Rokotov, D Mikus, G Buljat, ... Life sciences 68 (16), 1905-1912, 2001 | 52 | 2001 |
| Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat P Sikiric, S Seiwerth, G Aralica, D Perovic, M Staresinic, T Anic, ... Journal of Physiology-Paris 95 (1-6), 283-288, 2001 | 51 | 2001 |
Separovic J, Separovic-Hanzevacki J,...Professor of Cardiology, School of Medicine, University of ZagrebVerified email at kbc-zagreb.hr
